More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...

The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...

There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF Scripps Institute in Jupiter.

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...

Nursing home patients with HIV tend to be younger. They also typically have more comorbidities than the average patient, and ...

A twice-a-year injectable drug has been shown to be 100% effective in preventing the spread of HIV, according to the first data from a clinical trial. If approved, the drug offers another preventive ...

The proposed policy could help stem the spread of the virus. This is a KFF Health News story. A proposed federal policy aims to protect older Americans from contracting HIV by offering free preventive ...

Recent trends indicate a disturbing comeback of HIV/AIDS in parts of the Pacific, as the World Health Organisation prepares ...

In this Oct. 7, 2019, file photo, a pharmacist displays the HIV prevention drugs Descovy, left and Truvada, right, at a pharmacy in Sacramento, Calif. A proposed federal policy aims to protect older ...